Solid organ transplantation after haematopoietic stem cell transplantation in childhood: a multicentric retrospective survey

EBMT Pediatric Disease Working Party

Research output: Contribution to journalArticle

Abstract

We report data obtained from a retrospective multicenter pediatric survey on behalf of the European Society for Blood and Marrow Transplantation (EBMT). Information on Solid Organ Transplantation (SOT) performed in pediatric recipients of either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) between 1984 and 2016 were collected in 20 pediatric EBMT Centers (25.6%). Overall, we evaluated data on 44 SOTs following HSCT including 20 liver (LTx), 12 lung (LuTx), 6 heart (HTx), and 6 kidney (KTx) transplantations. The indication for SOT was organ failure related to intractable Graft-versus-Host Disease in 16 children (36.3%), acute or chronic HSCT-related toxicity in 18 (40.9%) and organ dysfunction related to the underlying disease in 10 (22.8%). The median follow-up was 10.9 years (95% CI: 1.7-29.5). The overall survival (OS) rate at 1 and 5 years after SOT was 85.7% and 80.4%, respectively: it was 74% and 63.2% after LTx, 83.2% after HTx, and 100% equally after LuTx and KTx. This multicenter survey confirms that SOT represents a promising option in children with severe organ failure occurred after HSCT. Additional studies are needed to further establish the effectiveness of SOT after HSCT and to better understand the mechanism underlying this encouraging success. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalAmerican Journal of Transplantation
DOIs
Publication statusE-pub ahead of print - Dec 26 2018

Fingerprint

Hematopoietic Stem Cell Transplantation
Organ Transplantation
Pediatrics
Transplantation
Bone Marrow
Graft vs Host Disease
Kidney Transplantation
Survival Rate
Surveys and Questionnaires
Lung
Liver

Cite this

Solid organ transplantation after haematopoietic stem cell transplantation in childhood : a multicentric retrospective survey. / EBMT Pediatric Disease Working Party.

In: American Journal of Transplantation, 26.12.2018.

Research output: Contribution to journalArticle

@article{94bd05ae8e3149f19cb5db39e8977da0,
title = "Solid organ transplantation after haematopoietic stem cell transplantation in childhood: a multicentric retrospective survey",
abstract = "We report data obtained from a retrospective multicenter pediatric survey on behalf of the European Society for Blood and Marrow Transplantation (EBMT). Information on Solid Organ Transplantation (SOT) performed in pediatric recipients of either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) between 1984 and 2016 were collected in 20 pediatric EBMT Centers (25.6{\%}). Overall, we evaluated data on 44 SOTs following HSCT including 20 liver (LTx), 12 lung (LuTx), 6 heart (HTx), and 6 kidney (KTx) transplantations. The indication for SOT was organ failure related to intractable Graft-versus-Host Disease in 16 children (36.3{\%}), acute or chronic HSCT-related toxicity in 18 (40.9{\%}) and organ dysfunction related to the underlying disease in 10 (22.8{\%}). The median follow-up was 10.9 years (95{\%} CI: 1.7-29.5). The overall survival (OS) rate at 1 and 5 years after SOT was 85.7{\%} and 80.4{\%}, respectively: it was 74{\%} and 63.2{\%} after LTx, 83.2{\%} after HTx, and 100{\%} equally after LuTx and KTx. This multicenter survey confirms that SOT represents a promising option in children with severe organ failure occurred after HSCT. Additional studies are needed to further establish the effectiveness of SOT after HSCT and to better understand the mechanism underlying this encouraging success. This article is protected by copyright. All rights reserved.",
author = "{EBMT Pediatric Disease Working Party} and M Faraci and A Bertaina and A Dalissier and M Ifversen and A Schulz and A Gennery and B Burkhardt and {Badell Serra}, I and C Diaz-de-Heredia and E Lanino and Lankester, {A C} and B Gruhn and S Matthes-Martin and K{\"u}hl, {J S} and S Varotto and C Paillard and A Guilmatre and A Sastre and M Abecasis and B Garwer and P Sedlacek and Boelens, {J J} and Eric Beohou and P Bader",
note = "This article is protected by copyright. All rights reserved.",
year = "2018",
month = "12",
day = "26",
doi = "10.1111/ajt.15240",
language = "English",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Solid organ transplantation after haematopoietic stem cell transplantation in childhood

T2 - a multicentric retrospective survey

AU - EBMT Pediatric Disease Working Party

AU - Faraci, M

AU - Bertaina, A

AU - Dalissier, A

AU - Ifversen, M

AU - Schulz, A

AU - Gennery, A

AU - Burkhardt, B

AU - Badell Serra, I

AU - Diaz-de-Heredia, C

AU - Lanino, E

AU - Lankester, A C

AU - Gruhn, B

AU - Matthes-Martin, S

AU - Kühl, J S

AU - Varotto, S

AU - Paillard, C

AU - Guilmatre, A

AU - Sastre, A

AU - Abecasis, M

AU - Garwer, B

AU - Sedlacek, P

AU - Boelens, J J

AU - Beohou, Eric

AU - Bader, P

N1 - This article is protected by copyright. All rights reserved.

PY - 2018/12/26

Y1 - 2018/12/26

N2 - We report data obtained from a retrospective multicenter pediatric survey on behalf of the European Society for Blood and Marrow Transplantation (EBMT). Information on Solid Organ Transplantation (SOT) performed in pediatric recipients of either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) between 1984 and 2016 were collected in 20 pediatric EBMT Centers (25.6%). Overall, we evaluated data on 44 SOTs following HSCT including 20 liver (LTx), 12 lung (LuTx), 6 heart (HTx), and 6 kidney (KTx) transplantations. The indication for SOT was organ failure related to intractable Graft-versus-Host Disease in 16 children (36.3%), acute or chronic HSCT-related toxicity in 18 (40.9%) and organ dysfunction related to the underlying disease in 10 (22.8%). The median follow-up was 10.9 years (95% CI: 1.7-29.5). The overall survival (OS) rate at 1 and 5 years after SOT was 85.7% and 80.4%, respectively: it was 74% and 63.2% after LTx, 83.2% after HTx, and 100% equally after LuTx and KTx. This multicenter survey confirms that SOT represents a promising option in children with severe organ failure occurred after HSCT. Additional studies are needed to further establish the effectiveness of SOT after HSCT and to better understand the mechanism underlying this encouraging success. This article is protected by copyright. All rights reserved.

AB - We report data obtained from a retrospective multicenter pediatric survey on behalf of the European Society for Blood and Marrow Transplantation (EBMT). Information on Solid Organ Transplantation (SOT) performed in pediatric recipients of either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) between 1984 and 2016 were collected in 20 pediatric EBMT Centers (25.6%). Overall, we evaluated data on 44 SOTs following HSCT including 20 liver (LTx), 12 lung (LuTx), 6 heart (HTx), and 6 kidney (KTx) transplantations. The indication for SOT was organ failure related to intractable Graft-versus-Host Disease in 16 children (36.3%), acute or chronic HSCT-related toxicity in 18 (40.9%) and organ dysfunction related to the underlying disease in 10 (22.8%). The median follow-up was 10.9 years (95% CI: 1.7-29.5). The overall survival (OS) rate at 1 and 5 years after SOT was 85.7% and 80.4%, respectively: it was 74% and 63.2% after LTx, 83.2% after HTx, and 100% equally after LuTx and KTx. This multicenter survey confirms that SOT represents a promising option in children with severe organ failure occurred after HSCT. Additional studies are needed to further establish the effectiveness of SOT after HSCT and to better understand the mechanism underlying this encouraging success. This article is protected by copyright. All rights reserved.

U2 - 10.1111/ajt.15240

DO - 10.1111/ajt.15240

M3 - Article

C2 - 30586230

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -